Theranica, a company based in Israel, won FDA De Novo clearance for its Nerivio Migra smartphone-operated electroceutical device for treating migraine headaches. The device is worn around the upper arm, from where it delivers electronic pulses into the skin to generate a so-called “Conditioned Pain Modulation” response. This helps to mitigate the effects of a migraine in patients with or without aura, and...